Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.6 USD -1.84% Intraday chart for CytomX Therapeutics, Inc. -7.51% +3.23%
Apr. 22 JPMorgan Upgrades CytomX Therapeutics to Neutral From Underweight MT
Apr. 08 CytomX Therapeutics, Inc. Announces First Patient Dosed with CX-2051, A Conditionally Activated EpCAM-Directed ADC, in A Phase 1 Study in Patients with Advanced Solid Tumors CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. News CytomX Therapeutics, Inc.
  5. Official Publications